AMLX · Amylyx Pharmaceuticals, Inc.

$21.63 -0.85 (-3.78%) At close · Aug 14

Market Cap

$2.41B

111.42M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed	Type	Industry	Offering	Sold	Min. Invest.	Investors	Exemptions
2020-07-01	New	Pharmaceuticals	$30,000,000	$30,000,000	$10,000	17	06b
2020-01-28	Amendment	Pharmaceuticals	$20,000,000	$14,773,328	$10,000	37	06b

Showing 1–2 of 2 filings

Key facts CIK 1658551 CUSIP 03237H101 13F (30d) 199 filings 197 filers Visit website Investor relations